These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 27316377)
21. CGK062, a small chemical molecule, inhibits cancer upregulated gene 2‑induced oncogenesis through NEK2 and β‑catenin. Kaowinn S; Oh S; Moon J; Yoo AY; Kang HY; Lee MR; Kim JE; Hwang DY; Youn SE; Koh SS; Chung YH Int J Oncol; 2019 Apr; 54(4):1295-1305. PubMed ID: 30968157 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice. Moriya C; Taniguchi H; Miyata K; Nishiyama N; Kataoka K; Imai K Carcinogenesis; 2017 Jun; 38(6):638-648. PubMed ID: 28498896 [TBL] [Abstract][Full Text] [Related]
23. Knockdown of ribosomal protein L39 by RNA interference inhibits the growth of human pancreatic cancer cells in vitro and in vivo. Li C; Chen D; Luo M; Ge M; Zhu J Biotechnol J; 2014 May; 9(5):652-63. PubMed ID: 24799381 [TBL] [Abstract][Full Text] [Related]
24. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738 [TBL] [Abstract][Full Text] [Related]
25. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles. Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377 [TBL] [Abstract][Full Text] [Related]
26. Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer. Kawata E; Ashihara E; Kimura S; Takenaka K; Sato K; Tanaka R; Yokota A; Kamitsuji Y; Takeuchi M; Kuroda J; Tanaka F; Yoshikawa T; Maekawa T Mol Cancer Ther; 2008 Sep; 7(9):2904-12. PubMed ID: 18790771 [TBL] [Abstract][Full Text] [Related]
27. Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome-wide shRNA screen. Kurahara H; Bohl C; Natsugoe S; Nishizono Y; Harihar S; Sharma R; Iwakuma T; Welch DR Int J Cancer; 2016 Aug; 139(3):628-38. PubMed ID: 27012470 [TBL] [Abstract][Full Text] [Related]
28. Effect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathway. Zhang MX; Xu XM; Zhang P; Han NN; Deng JJ; Yu TT; Gan YY; He XQ; Long ZX Tumour Biol; 2016 Feb; 37(2):2023-35. PubMed ID: 26337275 [TBL] [Abstract][Full Text] [Related]
29. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo. Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297 [TBL] [Abstract][Full Text] [Related]
30. NEK2 is associated with poor prognosis of clear cell renal cell carcinoma and promotes tumor cell growth and metastasis. Feng X; Jiang Y; Cui Y; Xu Y; Zhang Q; Xia Q; Chen Y Gene; 2023 Jan; 851():147040. PubMed ID: 36370999 [TBL] [Abstract][Full Text] [Related]
31. NIMA related kinase 2 promotes gastric cancer cell proliferation Fan WD; Chen T; Liu PJ World J Gastroenterol; 2019 Jun; 25(23):2898-2910. PubMed ID: 31249448 [TBL] [Abstract][Full Text] [Related]
32. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice. Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868 [TBL] [Abstract][Full Text] [Related]
33. Deguelin inhibits epithelial-to-mesenchymal transition and metastasis of human non-small cell lung cancer cells by regulating NIMA-related kinase 2. Zhao D; Han W; Liu X; Cui D; Chen Y Thorac Cancer; 2017 Jul; 8(4):320-327. PubMed ID: 28509438 [TBL] [Abstract][Full Text] [Related]
34. Preclinical activity of MBM-5 in gastrointestinal cancer by inhibiting NEK2 kinase activity. Fang Y; Kong Y; Xi J; Zhu M; Zhu T; Jiang T; Hu W; Ma M; Zhang X Oncotarget; 2016 Nov; 7(48):79327-79341. PubMed ID: 27764815 [TBL] [Abstract][Full Text] [Related]
35. A Rationally Optimized Nanoparticle System for the Delivery of RNA Interference Therapeutics into Pancreatic Tumors in Vivo. Teo J; McCarroll JA; Boyer C; Youkhana J; Sagnella SM; Duong HT; Liu J; Sharbeen G; Goldstein D; Davis TP; Kavallaris M; Phillips PA Biomacromolecules; 2016 Jul; 17(7):2337-51. PubMed ID: 27305597 [TBL] [Abstract][Full Text] [Related]
36. RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo. Chen Y; Xie D; Yin Li W; Man Cheung C; Yao H; Chan CY; Chan CY; Xu FP; Liu YH; Sung JJ; Kung HF Cancer Lett; 2010 Nov; 297(1):109-16. PubMed ID: 20684863 [TBL] [Abstract][Full Text] [Related]
37. Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells. Cappello P; Blaser H; Gorrini C; Lin DC; Elia AJ; Wakeham A; Haider S; Boutros PC; Mason JM; Miller NA; Youngson B; Done SJ; Mak TW Oncogene; 2014 May; 33(18):2375-84. PubMed ID: 23708664 [TBL] [Abstract][Full Text] [Related]
38. Role of NIMA-related kinase 2 in lung cancer: Mechanisms and therapeutic prospects. Shah D; Joshi M; Patel BM Fundam Clin Pharmacol; 2022 Oct; 36(5):766-776. PubMed ID: 35338518 [TBL] [Abstract][Full Text] [Related]
39. FBXW7 circular RNA regulates proliferation, migration and invasion of colorectal carcinoma through NEK2, mTOR, and PTEN signaling pathways in vitro and in vivo. Lu H; Yao B; Wen X; Jia B BMC Cancer; 2019 Sep; 19(1):918. PubMed ID: 31519156 [TBL] [Abstract][Full Text] [Related]